LONDON – Identification of a protein that orchestrates many of the changes that permit a normal cell to turn into a cancer cell will open up an entirely new field of cancer therapeutics, the researchers who made the discovery predicted.
LONDON – While the development of biosimilars – biological medicines designed to be very similar to ones that have already been approved for clinical use – is really still in its infancy, people already are looking to the future and considering what sorts of molecules will come next.
LONDON – How different does a drawing of an elephant have to be before it stops looking like an elephant? How similar does a fingerprint have to be before we can say it is the same as the one found at the crime scene?
LONDON – If the European market for biosimilars could be worth $4 billion by 2017, why has progress been so slow in gaining market authorizations for biosimilars in recent years?
LONDON – 2013 will be a watershed year for biosimilars – biological therapies designed to be similar to existing biological therapeutic agents – delegates attending the Second Biosimilars Congregation in London heard Tuesday.
LONDON – 2013 will be a watershed year for biosimilars – biological therapies designed to be similar to existing biological therapeutic agents – delegates attending the Second Biosimilars Congregation in London heard Tuesday.
With the discovery of 24 new genes that are linked to myopia, or short-sightedness, most of the hereditary causes of this condition are now known, researchers contend.
Successful treatment of cancer depends not on killing tumor cells, but in beating them into submission using the immune system, a team of German researchers reported. They have identified a type of immune cell that can "re-educate" cancer cells, so that they enter prolonged periods of growth arrest.
Successful treatment of cancer depends not on killing tumor cells, but in beating them into submission using the immune system, a team of German researchers reported. They have identified a type of immune cell that can "re-educate" cancer cells, so that they enter prolonged periods of growth arrest.
A family that has 14 members affected by an aggressive form of malignant melanoma has helped researchers discover a new mutation that is common in melanoma tumors and could lead to new, targeted treatments for that type of cancer.
